Autoimmunity against human tropomyosin isoforms in ulcerative colitis: Localization of specific human tropomyosin isoforms in the intestine and extraintestinal organs

Background: Tropomyosins (TMs) are microfilament cytoskeletal proteins, and 5 major human TM isoforms (hTM1‐5) are described. hTMs, particularly isoform 5 (hTM5), is capable of inducing autoantibodies and T‐cell response in ulcerative colitis (UC). However, cellular localization of hTM isoforms in the colon and in extraintestinal organs commonly involved in UC is unknown. Methods: Using isoform‐specific monoclonal antibodies, we localized hTMs through immunoperoxidase assay in normal colon (n = 12), small intestine (n = 14), esophagus (n = 10), skin (n = 19), eye (n = 12), gallbladder (n = 16), liver, including bile duct at the porta hepatis (n = 4), lungs (n = 4), and pancreas (n = 4). Results: There is intense expression of hTM5, but not other isoforms, in the epithelium of the colon, gallbladder, and skin. In the eye, hTM5 is expressed only in the nonpigmented ciliary epithelium. Although extrahepatic and interlobar large ductal biliary epithelium was positive, bile canaliculi at the portal tract are negative. The immunoreactivity in epithelial cells from these organs is diffuse cytoplasmic and along the periphery. In colon epithelium, there is intense expression along basolateral areas and luminal (apical) surface. In the small intestinal epithelium, however, hTM5 expression is weak and distinctly different than in the colon. hTM5 was not detected in the squamous epithelium of the esophagus, although it was strongly positive in the skin. hTM1, hTM2, and hTM3 are localized predominantly in smooth muscle of the intestine and blood vessel wall but not the epithelium. HTM4 is localized in the endothelial cells and basement membrane of the colonic epithelium. Conclusions: hTM5 is the predominant isoform in the epithelium of colon and extraintestinal organs commonly involved in UC. The unique expression of hTM5 may allow its interaction with effector immune cells involved in the immunopathogenesis of UC and its extraintestinal manifestations.

[1]  L. Biancone,et al.  Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis , 2003, American Journal of Gastroenterology.

[2]  D. Drucker.  Biological actions and therapeutic potential of the glucagon-like peptides. , 2002, Gastroenterology.

[3]  X. Geng,et al.  Cellular immune response against tropomyosin isoform 5 in ulcerative colitis. , 2001, Clinical immunology.

[4]  K. Ramaswamy,et al.  Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5 , 2000, Clinical and experimental immunology.

[5]  T. Takayama,et al.  Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells , 2000, Gut.

[6]  Das,et al.  Externalization of tropomyosin isoform 5 in colon epithelial cells , 1999, Clinical and experimental immunology.

[7]  Pallone,et al.  Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives , 1998, Clinical and experimental immunology.

[8]  L. Biancone,et al.  Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis. , 1998, Gastroenterology.

[9]  J. Lin,et al.  Tropomyosin isoforms in nonmuscle cells. , 1997, International review of cytology.

[10]  E. Mizoguchi,et al.  Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice , 1996, The Journal of experimental medicine.

[11]  S. Tonegawa,et al.  Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease , 1996, The Journal of experimental medicine.

[12]  L. Biancone,et al.  Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis. , 1995, Gastroenterology.

[13]  T. Wada,et al.  Immunochemical characterization of recombinant and native tropomyosins as a new allergen from the house dust mite, Dermatophagoides farinae. , 1995, The Journal of allergy and clinical immunology.

[14]  J. Lin,et al.  Forced expression of chimeric human fibroblast tropomyosin mutants affects cytokinesis , 1995, The Journal of cell biology.

[15]  G. Reese,et al.  Identification of the major brown shrimp (Penaeus aztecus) allergen as the muscle protein tropomyosin. , 1994, International archives of allergy and immunology.

[16]  K. Das,et al.  A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody. , 1994, Gastroenterology.

[17]  P. Amenta,et al.  Detection of a Shared Colon Epithelial Epitope on Barrett Epithelium by a Novel Monoclonal Antibody , 1994, Annals of Internal Medicine.

[18]  A. Lupas,et al.  Long charge-rich alpha-helices in systemic autoantigens. , 1993, Biochemical and Biophysical Research Communications - BBRC.

[19]  T. Halstensen,et al.  Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis. , 1993, Gut.

[20]  D. Helfman,et al.  Expression of smooth muscle and nonmuscle tropomyosins in Escherichia coli and characterization of bacterially produced tropomyosins. , 1993, Biochimica et biophysica acta.

[21]  X. Geng,et al.  Autoimmunity to cytoskeletal protein tropomyosin. A clue to the pathogenetic mechanism for ulcerative colitis. , 1993, Journal of immunology.

[22]  J. Sellers,et al.  In vitro functional characterization of bacterially expressed human fibroblast tropomyosin isoforms and their chimeric mutants. , 1993, Cell motility and the cytoskeleton.

[23]  C. Lin,et al.  Human fibroblast tropomyosin isoforms: characterization of cDNA clones and analysis of tropomyosin isoform expression in human tissues and in normal and transformed cells. , 1993, Cell motility and the cytoskeleton.

[24]  T. Halstensen,et al.  Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis. , 1992, Gut.

[25]  H. Ogata,et al.  In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis. , 1990, Gut.

[26]  G. Hellers,et al.  Extracolonic diagnoses in ulcerative colitis: an epidemiological study. , 1990, The American journal of gastroenterology.

[27]  S. Sakamaki,et al.  A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. , 1990, Gastroenterology.

[28]  J. Lin,et al.  Differential localization of tropomyosin isoforms in cultured nonmuscle cells , 1988, The Journal of cell biology.

[29]  B. Diamond,et al.  The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. , 1987, Journal of immunology.

[30]  K. Das,et al.  Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis. , 1985, The Journal of clinical investigation.

[31]  J. Lin,et al.  Monoclonal antibodies against chicken tropomyosin isoforms: production, characterization, and application. , 1985, Hybridoma.

[32]  H. Sanfey,et al.  Sclerosing Cholangitis: Anatomical Distribution of Obstructive Lesions , 1984, Annals of surgery.

[33]  V. Fowler,et al.  Erythrocyte membrane tropomyosin. Purification and properties. , 1984, The Journal of biological chemistry.

[34]  E. Schrumpf,et al.  Sclerosing cholangitis in ulcerative colitis. A follow-up study. , 1982, Scandinavian journal of gastroenterology.

[35]  K. Das,et al.  Isolation and characterization of colonic tissue-bound antibodies from patients with idiopathic ulcerative colitis. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Perlmann,et al.  AUTOANTIBODIES IN HUMAN ULCERATIVE COLITIS , 1959, The Journal of experimental medicine.